Chemotherapy-Induced Neuropathy

Overview

Chemotherapy-induced peripheral neuropathy (CIPN) is nerve damage caused by certain medicines used to treat cancer. Some chemotherapy drugs that kill or slow cancer cells can also harm the peripheral nerves, the nerves outside the brain and spinal cord that carry sensation and movement signals.

The result is usually numbness, tingling, pain, and sometimes weakness, most often in the hands and feet. It is a common side effect of several chemotherapy types. For many people it improves gradually after treatment ends, though for some it can be long-lasting and may influence how chemotherapy is dosed.

Symptoms

Symptoms usually affect the hands and feet on both sides and may build up over the course of treatment:

• Tingling, pins-and-needles, or numbness in the fingers and toes
• Burning, shooting, or stabbing pain
• Increased sensitivity to touch or to cold
• Weakness or clumsiness, with trouble buttoning clothes or gripping objects
• Balance problems and an unsteady walk
• Reduced ability to feel temperature, raising the risk of unnoticed burns or injuries

Some chemotherapy drugs cause sudden cold sensitivity. Symptoms vary with the drug, the dose, and the individual.

Causes

CIPN is caused by the toxic effect of specific chemotherapy drugs on peripheral nerves. Several classes of chemotherapy are known to cause it more often, including certain platinum-based drugs, taxanes, vinca alkaloids, and some others. These medicines can damage the long nerve fibers that reach the hands and feet.

The likelihood and severity depend on the particular drug, the total dose, how it is given, and individual factors. The damage is not a sign that the cancer is spreading; it is a side effect of the treatment itself.

Risk Factors

• Treatment with chemotherapy drugs known to affect nerves
• Higher cumulative doses or longer courses of these drugs
• Pre-existing nerve problems, such as diabetic neuropathy
• Other causes of nerve damage, including heavy alcohol use or vitamin deficiencies
• Older age

Diagnosis

Diagnosis is usually based on the symptoms and their timing in relation to chemotherapy:

• History and examination: Reviewing which drugs were given and testing sensation, strength, reflexes, and balance.
• Ruling out other causes: Blood tests may check for other contributors such as diabetes or vitamin deficiency.
• Nerve studies: Occasionally used to assess the type and extent of nerve damage.

Because symptoms can affect quality of life and safety, the care team monitors for them during treatment.

Treatment

Management focuses on adjusting treatment when needed, relieving symptoms, and keeping people safe.

• Adjusting chemotherapy: The oncology team may change the dose, slow the schedule, or switch drugs if neuropathy becomes significant, balancing this against cancer treatment goals.
• Pain relief: Certain medicines used for nerve pain can ease burning and shooting symptoms in some people.
• Physical and occupational therapy: Helps with strength, balance, coordination, and daily tasks.
• Safety measures: Protecting numb hands and feet from burns, cuts, and falls.

For many people symptoms ease over the months after chemotherapy finishes, although recovery can be slow and sometimes incomplete.

Prevention

There is no guaranteed way to prevent CIPN, but the care team works to reduce its impact:

• Monitoring symptoms closely during treatment so doses can be adjusted early
• Reporting new numbness, tingling, or pain promptly rather than waiting
• Managing other nerve risk factors, such as diabetes, alcohol use, and vitamin deficiencies
• Following advice to protect numb hands and feet and prevent injury

When to See a Doctor

Tell your cancer care team promptly if you develop tingling, numbness, pain, weakness, or balance problems during or after chemotherapy. Reporting symptoms early allows treatment to be adjusted before nerve damage becomes severe.

Seek urgent care for sudden, rapidly worsening weakness, difficulty walking, or signs of injury to numb areas, such as unnoticed wounds or burns, which need timely attention.

Related Topics

Frequently Asked Questions

References

1. National Cancer Institute (NCI). Peripheral Neuropathy and Cancer Treatment.
2. American Cancer Society. Peripheral neuropathy caused by chemotherapy.
3. National Institute of Neurological Disorders and Stroke (NINDS). Peripheral Neuropathy.
4. MedlinePlus, U.S. National Library of Medicine. Peripheral neuropathy.